Predictmedix Inc.
PMEDF · OTC
10/31/2025 | 7/31/2025 | 4/30/2025 | 1/31/2025 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.11 | 0.08 | 0.13 | -0.02 |
| FCF Yield | -0.41% | -6.33% | -10.84% | 0.00% |
| EV / EBITDA | -24.20 | -16.89 | -15.27 | -24.70 |
| Quality | ||||
| ROIC | 38.60% | 18.02% | 39.06% | 12.59% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.10 | 1.27 | 1.69 | – |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -100.00% | -100.00% |
| Free Cash Flow Growth | 87.52% | 66.86% | 0.00% | 100.00% |
| Safety | ||||
| Net Debt / EBITDA | 1.03 | 0.71 | 0.95 | 0.00 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -23,326.66 | -21,799.42 | 0.00 | 0.00 |